Endocrine evaluation of erectile dysfunction

摘要: Erectile dysfunction is highly prevalent, affecting up to half of men in their 50-70s, and has been variably associated a variety causes including unhealthy lifestyles, such as smoking or overweight, comorbidities hypertension, diabetes mellitus, neurological disorders. General interest toward ED exploded since the introduction phosphodiesterase type 5 inhibitors—oral drugs that are widely accepted first line treatment patients suffering from this conditions. In last decade, time lapse between symptoms sexual disorders seeking medical advice greatly reduced. Unfortunately, none PDE5i proven curative, but rather acts symptomatic treatment. The availability very active safe drugs, however, diminished space for diagnosis search etiological treatments. This particularly true several endo- crinopathies with ED. A number epidemio- logical data support an inverse relationship health testosterone levels, it well deficiency good marker physical frailty. However, other hormones, LH, prolactin, TSH, FT4 involved functioning should be investigated proper work-out Existing guidelines provide information almost entirely focusing on late-onset hypogonadism therapeutic strategies; mini-review aims wider spectrum diagnostic endocrine unrevealing complexity conditions, overt subclinical, which can affect